Caroline Chiles to Lung Neoplasms
This is a "connection" page, showing publications Caroline Chiles has written about Lung Neoplasms.
Connection Strength
3.598
-
Christensen JD, Chiles C. Low-dose computed tomographic screening for lung cancer. Clin Chest Med. 2015 Jun; 36(2):147-60, vii.
Score: 0.374
-
Chiles C. Low dose CT screening for lung cancer: moving into the clinical arena. J Thorac Imaging. 2015 Mar; 30(2):77-8.
Score: 0.371
-
Shroff GS, Guirguis MS, Ocazionez D, Oldham SA, Restrepo CS, Chiles C. Beyond metastatic disease: a pictorial review of multinodular lung disease with computed tomographic pathologic correlation. Can Assoc Radiol J. 2015 Feb; 66(1):16-23.
Score: 0.369
-
Chiles C. Lung cancer screening with low-dose computed tomography. Radiol Clin North Am. 2014 Jan; 52(1):27-46.
Score: 0.342
-
Chiles C, Paul NS. Beyond lung cancer: a strategic approach to interpreting screening computed tomography scans on the basis of mortality data from the National Lung Screening Trial. J Thorac Imaging. 2013 Nov; 28(6):347-54.
Score: 0.338
-
Chiles C. Lung cancer screening: achieving a reduction in mortality. Semin Roentgenol. 2011 Jul; 46(3):230-40.
Score: 0.288
-
Hopkins RJ, Duan F, Gamble GD, Chiles C, Cavadino A, Billings P, Aberle D, Young RP. Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers. Thorax. 2021 03; 76(3):272-280.
Score: 0.139
-
Schneider BJ, Ismaila N, Aerts J, Chiles C, Daly ME, Detterbeck FC, Hearn JWD, Katz SI, Leighl NB, Levy B, Meyers B, Murgu S, Nekhlyudov L, Santos ES, Singh N, Tashbar J, Yankelevitz D, Altorki N. Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. J Clin Oncol. 2020 03 01; 38(7):753-766.
Score: 0.129
-
Munden RF, Chiles C, Boiselle PM, Sicks JD, Aberle DR, Gatsonis CA. Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer. J Thorac Oncol. 2019 09; 14(9):1538-1546.
Score: 0.125
-
Carlos RC, Sicks JD, Chiles C, Gansauer L, Kamen CS, Kazak AE, Neuman HB, Unger JM, Weaver KE. Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization. J Am Coll Radiol. 2019 Apr; 16(4 Pt A):427-434.
Score: 0.122
-
Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, Fu SS, Graham AL, Lindgren BR, Melzer AC, Ostroff JS, Seaman EL, Taylor KL, Toll BA, Zeliadt SB, Vock DM. Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration. Am J Respir Crit Care Med. 2018 01 15; 197(2):172-182.
Score: 0.113
-
Hopkins RJ, Duan F, Chiles C, Greco EM, Gamble GD, Aberle D, Young RP. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort. Ann Am Thorac Soc. 2017 Mar; 14(3):392-402.
Score: 0.107
-
McComb BL, Munden RF, Duan F, Jain AA, Tuite C, Chiles C. Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial. Clin Imaging. 2016 Sep-Oct; 40(5):936-43.
Score: 0.100
-
Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. Am J Respir Crit Care Med. 2015 Nov 01; 192(9):1060-7.
Score: 0.097
-
Chiles C, Duan F, Gladish GW, Ravenel JG, Baginski SG, Snyder BS, DeMello S, Desjardins SS, Munden RF. Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. Radiology. 2015 Jul; 276(1):82-90.
Score: 0.093
-
Lewis JA, Petty WJ, Tooze JA, Miller DP, Chiles C, Miller AA, Bellinger C, Weaver KE. Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):664-70.
Score: 0.092
-
Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst. 2014 Nov; 106(11).
Score: 0.090
-
Boiselle PM, Chiles C, Patz E, Tammemägi M, Wood DE. Expert opinion: United States Preventive Services Task Force recommendation on screening for lung cancer. J Thorac Imaging. 2014 Jul; 29(4):197.
Score: 0.089
-
Patz EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014 Feb 01; 174(2):269-74.
Score: 0.086
-
Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial. Clin Trials. 2011 Apr; 8(2):214-23.
Score: 0.070
-
Park ER, Chiles C, Cinciripini PM, Foley KL, Fucito LM, Haas JS, Joseph AM, Ostroff JS, Rigotti NA, Shelley DR, Taylor KL, Zeliadt SB, Toll BA. Impact of the COVID-19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances. Cancer. 2021 02 01; 127(3):334-338.
Score: 0.034
-
Tsai EB, Chiles C, Carter BW, Godoy MCB, Shroff GS, Munden RF, Truong MT, Wu CC. Incidental Findings on Lung Cancer Screening: Significance and Management. Semin Ultrasound CT MR. 2018 Jun; 39(3):273-281.
Score: 0.029